2001
DOI: 10.1097/00043426-200112000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Low Relapse Rate in Children With Acute Lymphoblastic Leukemia After Risk-Directed Therapy

Abstract: The modification proved to be effective in diminishing the therapeutic toxicity and improving the efficacy, mainly for the high-risk group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0
1

Year Published

2003
2003
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 24 publications
0
15
0
1
Order By: Relevance
“…8,9 This protocol includes corticosteroids for all the patients both in induction-consolidation phase and maintenance phase. Patients with clinical or radiologic findings of acute or chronic infection were excluded.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…8,9 This protocol includes corticosteroids for all the patients both in induction-consolidation phase and maintenance phase. Patients with clinical or radiologic findings of acute or chronic infection were excluded.…”
Section: Methodsmentioning
confidence: 99%
“…The interval between the completion of last chemotherapy regimen and blood sample collection was at least 2 weeks. 9 Physical examination, including BMI measurement, was performed at the same time points. BMI SD (standard deviation) scores were determined calculating the SD from the mean value of BMI for the respective age and sex of every individual.…”
Section: Methodsmentioning
confidence: 99%
“…Survival figures for certain hematological malignancies have improved dramatically: 5-year survival from childhood acute lymphoblastic leukemia was less than 40% in the 1970s, while is now approaching 80%. 1,2 However, the chemotherapeutic treatment outcome for most adults with acute myeloid leukemia remains unacceptable. 3 Indeed, it seems that we have reached the limits of our ability to kill cancer cells that are intrinsically resistant to chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…In HOPDA‐91 (1991–1993, Table 1), LR patients received a combination of UKALL XI (induction) and R blocks of ALL‐REZ BFM‐87 (intensification) whereas HR patients received the NY II regimen (13). However, four cases, all in the HR group, died during the consolidation phase due to complications (three septicemias, one Aspergillus fumigatus infection) (14). Furthermore, a boy with LR leukemia had an early relapse but achieved a second remission.…”
Section: Methodsmentioning
confidence: 99%